Bevacizumab Impact on Hearing Loss Due to Neurofibromatosis Type 2 Associated Vestibular Schwannomas and Associated Biomarkers.

Speakers:
Jo Blakeley, Amanda Bergner
Conference:
AAN 2016
Friday, Apr 15, 2016 3:00pm – 5:00pm